Mice that underwent Roux-en-Y gastric bypass developed primary colorectal tumors that were significantly smaller and exhibited almost no liver metastases compared with sham-operated controls.

Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB) are explored. Summary The prevalence of obesity, especially morbid obesity, has dramatically ...

Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients April Smith; Brian Henriksen; Andrew Cohen Disclosures Am J Health Syst Pharm. 2011;68 (23):2241-2247.

The study was a retrospective comparative effectiveness study using the real-world electronic medical record data of NYU Langone Health and NYC Health + Hospitals patients with a body mass index (BMI) ...

Introduction Previous studies have demonstrated that one anastomosis gastric bypass (OAGB) is not inferior to Roux-en-Y gastric bypass (RYGB) in treating obesity. However, high level evidence ...

METHODS: An experimental protocol was conducted to evaluate postoperative gastric bypassed motility in dogs submitted to the Roux-en-Y gastric bypass procedure. Two groups of five animals were studied ...

The side-to-side "Roux-en-Y" hepaticojejunostomy is carried through transmesocolic, retrogastric short tunnel. A distal jejunal loop of approximately 10,0 to 15,0 cm must be kept far from the ...

We reviewed the need and outcome of medium/long-term jejunal feeding for problematic gastric HETF. Methods Retrospective cohort study (database and clinical note review) of use of polyethylene glycol ...

The following complications may arise in connection with laparascopic Roux-en-Y gastric bypass (LRYGBP): anastomatic strictures, ileus, and formation of fistulas and abscesses. This applies both to ...

Although choledochoduodenostomy was widely performed for choledocholithiasis in the 1960s and 1970s, Roux-en-Y hepaticojejunostomy is currently the preferred biliary-enteric anastomosis for benign and ...